As some segments of real estate have struggled during the pandemic, life sciences is taking off.
To capture some of this demand, institutional investors in the largest life science markets are actively reevaluating "highest and best use" for their office, flex and industrial portfolios, according to a new report by Newmark.
Many of these investors are considering converting these office, flex and industrial portfolios to meet immediate life science demand. The problem is that developing life sciences building is a highly technical pursuit, and life sciences developers and operators have several advantages in the sector.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Leslie Shaver
Les Shaver has been covering commercial and residential real estate for almost 20 years. His work has appeared in Multifamily Executive, Builder, units, Arlington Magazine in addition to GlobeSt.com and Real Estate Forum.
